{"id":"https://openalex.org/W7225814408","doi":"https://doi.org/10.3389/fcvm.2026.2020504","title":"Case Report: Early Chinese experience with caplacizumab for plasma-exchange-refractory immune-mediated TTP and a focused review of short-course treatment","display_name":"Case Report: Early Chinese experience with caplacizumab for plasma-exchange-refractory immune-mediated TTP and a focused review of short-course treatment","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225814408","doi":"https://doi.org/10.3389/fcvm.2026.2020504"},"language":"en","primary_location":{"id":"doi:10.3389/fcvm.2026.2020504","doi":"https://doi.org/10.3389/fcvm.2026.2020504","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.2020504","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.2020504/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.2020504/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5161464785","display_name":"Xiaoyan Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141719","display_name":"University of Hong Kong - Shenzhen Hospital","ror":"https://ror.org/047w7d678","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141719"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Xiaoyan Huang","raw_affiliation_strings":["Department of Rheumatology and Immunology, The University of Hong Kong-Shenzhen Hospital","Shenzhen Clinical Research Center for Rare Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology and Immunology, The University of Hong Kong-Shenzhen Hospital","institution_ids":["https://openalex.org/I4210141719"]},{"raw_affiliation_string":"Shenzhen Clinical Research Center for Rare Diseases","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075329296","display_name":"\u6b66\u5cad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141719","display_name":"University of Hong Kong - Shenzhen Hospital","ror":"https://ror.org/047w7d678","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141719"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ling Wu","raw_affiliation_strings":["Department of Rheumatology and Immunology, The University of Hong Kong-Shenzhen Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology and Immunology, The University of Hong Kong-Shenzhen Hospital","institution_ids":["https://openalex.org/I4210141719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5133087711","display_name":"Lijun Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141719","display_name":"University of Hong Kong - Shenzhen Hospital","ror":"https://ror.org/047w7d678","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210141719"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lijun Zhang","raw_affiliation_strings":["Department of Rheumatology and Immunology, The University of Hong Kong-Shenzhen Hospital","Shenzhen Clinical Research Center for Rare Diseases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology and Immunology, The University of Hong Kong-Shenzhen Hospital","institution_ids":["https://openalex.org/I4210141719"]},{"raw_affiliation_string":"Shenzhen Clinical Research Center for Rare Diseases","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5161464785"],"corresponding_institution_ids":["https://openalex.org/I4210141719"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.852400004863739},{"id":"https://openalex.org/C2780921031","wikidata":"https://www.wikidata.org/wiki/Q14873945","display_name":"ADAMTS13","level":4,"score":0.7329000234603882},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6895999908447266},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6492000222206116},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.4641999900341034},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4620000123977661},{"id":"https://openalex.org/C2910749824","wikidata":"https://www.wikidata.org/wiki/Q603502","display_name":"Therapeutic plasma exchange","level":2,"score":0.42260000109672546},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.35249999165534973},{"id":"https://openalex.org/C2778585876","wikidata":"https://www.wikidata.org/wiki/Q1426491","display_name":"Thrombotic thrombocytopenic purpura","level":3,"score":0.32280001044273376},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.30000001192092896},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2946999967098236},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.26669999957084656},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.26260000467300415},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2596000134944916}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fcvm.2026.2020504","doi":"https://doi.org/10.3389/fcvm.2026.2020504","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.2020504","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.2020504/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fcvm.2026.2020504","doi":"https://doi.org/10.3389/fcvm.2026.2020504","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.2020504","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.2020504/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225814408.pdf","grobid_xml":"https://content.openalex.org/works/W7225814408.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1999997909","https://openalex.org/W2079296861","https://openalex.org/W2605728624","https://openalex.org/W2910737538","https://openalex.org/W3022289262","https://openalex.org/W3119376015","https://openalex.org/W3128829816","https://openalex.org/W3192037313","https://openalex.org/W4200249097","https://openalex.org/W4228997343","https://openalex.org/W4288456718","https://openalex.org/W4289519858","https://openalex.org/W4315927645","https://openalex.org/W4317940543","https://openalex.org/W4385239350","https://openalex.org/W4385898264","https://openalex.org/W4398146864","https://openalex.org/W4402076100","https://openalex.org/W4409048803","https://openalex.org/W4411370089","https://openalex.org/W4413783555","https://openalex.org/W7128630958","https://openalex.org/W7131663798","https://openalex.org/W7138921168","https://openalex.org/W7154697662","https://openalex.org/W7204271709"],"related_works":[],"abstract_inverted_index":{"Caplacizumab":[0],"has":[1],"transformed":[2],"acute":[3],"immune-mediated":[4],"thrombotic":[5],"thrombocytopenic":[6],"purpura":[7],"(iTTP)":[8],"care,":[9],"but":[10,109,186],"experience":[11],"in":[12],"mainland":[13,159],"China":[14],"remains":[15],"limited.":[16],"We":[17],"report":[18],"a":[19,65,100,175,191],"53-year-old":[20],"woman":[21],"with":[22,137,151,174,204],"Sj\u00f6gren's":[23],"disease":[24],"and":[25,37,88,123,139,162,223],"iTTP":[26,135],"complicated":[27],"by":[28,64],"cerebral":[29],"infarctions.":[30],"Despite":[31],"corticosteroids,":[32],"two":[33,117],"early":[34,144],"rituximab":[35,119],"doses,":[36,120],"more":[38],"than":[39],"ten":[40],"therapeutic":[41],"plasma":[42,101],"exchange":[43],"(TPE)":[44],"sessions,":[45],"her":[46],"platelet":[47,67,86,177],"response":[48],"was":[49,95,105,147,181],"not":[50,188],"sustained,":[51],"meeting":[52],"traditional":[53],"criteria":[54],"for":[55],"TPE-refractory":[56],"disease.":[57],"Five":[58],"daily":[59],"caplacizumab":[60,145,180],"doses":[61,76],"were":[62,77,92],"followed":[63],"rapid":[66,176],"increase":[68],"to":[69,165,183,225],"631":[70],"\u00d7":[71],"10":[72],"9":[73],"/L.":[74],"Further":[75],"withheld":[78],"because":[79,98],"of":[80,99,133],"safety":[81],"concerns":[82],"about":[83],"the":[84],"marked":[85],"rise,":[87],"additional":[89],"drug":[90],"supplies":[91],"unavailable.":[93],"TPE":[94,108,114,138],"subsequently":[96],"stopped":[97],"shortage.":[102],"ADAMTS13":[103,121,153,218],"activity":[104],"72.73%":[106],"during":[107],"remained":[110],"below":[111],"10%":[112],"after":[113,168,179],"cessation.":[115],"After":[116],"further":[118],"recovered,":[122],"clinical":[124,221],"remission":[125],"persisted":[126],"through":[127],"September":[128],"2026.":[129],"A":[130],"focused":[131],"review":[132],"adult":[134],"treated":[136],"immunosuppression":[140],"found":[141],"that":[142,190,197],"successful":[143],"discontinuation":[146],"most":[148],"consistently":[149],"associated":[150],"serial":[152,217],"recovery.":[154],"Treatment":[155],"preceded":[156],"another":[157],"detailed":[158],"Chinese":[160],"report,":[161],"follow-up":[163],"extends":[164],"18":[166],"months":[167],"discharge.":[169],"Her":[170],"course":[171,193],"is":[172,194],"consistent":[173],"effect":[178],"added":[182],"standard":[184,215],"treatment,":[185],"does":[187],"establish":[189],"short":[192],"sufficient":[195],"or":[196,207],"it":[198],"reduces":[199],"bleeding":[200],"risk.":[201],"In":[202],"settings":[203],"restricted":[205],"access":[206,224],"reimbursement,":[208],"shorter":[209],"courses":[210],"warrant":[211],"prospective":[212],"evaluation":[213],"alongside":[214],"immunosuppression,":[216],"monitoring,":[219],"close":[220],"surveillance,":[222],"rescue":[226],"therapy.":[227]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}